Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy. [electronic resource]
Producer: 20060209Description: 1187-97 p. digitalISSN:- 0969-7128
- Adenoviridae -- genetics
- Aziridines -- administration & dosage
- Cell Line, Tumor
- Enzyme Activation
- Genetic Therapy -- methods
- Genetic Vectors -- administration & dosage
- Humans
- NF-kappa B -- metabolism
- Neoplasms -- metabolism
- Nitroreductases -- genetics
- Oncolytic Virotherapy -- methods
- Oncolytic Viruses -- genetics
- Prodrugs -- administration & dosage
- Signal Transduction
- Virus Replication
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.